99.7% PURITY LOT VL-2757-A SS-31
A mitochondria-targeted peptide supplied as a 10 mg lyophilized vial for research into mitochondrial function and oxidative stress.
- 1 × SS-31 10mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
About this compound
A mitochondria-targeted peptide supplied as a 10 mg lyophilized vial for research into mitochondrial function and oxidative stress.
- 10 mg lyophilized peptide per vial
- Mitochondria-targeted tetrapeptide
- Synthetic peptide, ≥99% purity
- Studied for ATP synthesis and oxidative stress
Why the lot matters
- Synthesized and tested per lot, never as a production-run average
- Certificate of Analysis published before the lot goes on sale
- Independent lab, contractually separate from manufacturing
What "research use only" means
This product is sold exclusively for in-vitro laboratory research. It is not evaluated by any medicines agency and is not intended for human or animal administration, diagnosis, treatment, or prevention of disease.
Technical data
Current lot snapshot
Shipping
Reported use in research
SS-31 is a mitochondria-targeted tetrapeptide studied for its ability to improve mitochondrial function and support ATP synthesis. It concentrates on the inner mitochondrial membrane, where it interacts with cardiolipin, and has been investigated for reducing inflammatory cytokines and oxidative stress associated with a range of degenerative conditions.
Reported findings
Research has shown SS-31 can stabilize cardiolipin and improve electron-transport efficiency, reducing reactive oxygen species. It has been investigated in models of heart disease, kidney injury, and neurodegenerative conditions such as Alzheimer’s and Parkinson’s, where mitochondrial dysfunction plays a role.
Handling & safety
In clinical research (as elamipretide), SS-31 has generally been well tolerated, with injection-site reactions among the more commonly reported observations. Formal safety characterization is ongoing across the conditions under study.
Reconstitution
Recommended ratio
- 1 mL of bacteriostatic water per 10 mg vial
- Equivalent to 10 mg/mL (i.e. 1 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Storage
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 639.8 g/mol | PASS |
| Purity | HPLC (area %) | 99.7% | PASS |
| Net peptide content | Gravimetric | 10.03 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 639.8 g/mol | PASS |
| Purity | HPLC (area %) | 99.6% | PASS |
| Net peptide content | Gravimetric | 10.04 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
| Lot | Filled | Purity | Report | Status | |
|---|---|---|---|---|---|
| VL-2757-A | Jul 2026 | 99.7% | TR-88509 | Active | |
| VL-2738-B | May 2026 | 99.6% | TR-88424 | Sold out |
